NCT04906863 is a clinical trial of Blood draw in Dementia, Early Onset, sponsored by Columbia University.

Who is sponsoring NCT04906863?

NCT04906863 is sponsored by Columbia University.

What drugs are being tested in NCT04906863?

Interventions in NCT04906863: Blood draw, Neurocognitive testing, Medical questionnaire.

What condition does NCT04906863 study?

NCT04906863 studies Dementia, Early Onset.

Is NCT04906863 still recruiting?

NCT04906863 is currently recruiting now. Last updated 29 April 2025.

Last reviewed 2025-04-29 · How we verify

NCT04906863

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Genetic Studies of Early-onset Dementia

Recruiting now Last updated 29 April 2025

What this trial tests

trial testing Blood draw in Dementia, Early Onset in 1,000 participants. Currently enrolling.

Timeline

14 September 2016

Primary endpoint
30 April 2028

30 April 2028

Quick facts

Lead sponsor	Columbia University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	14 September 2016
Primary completion	30 April 2028
Estimated completion	30 April 2028
Sites	1 location across United States

Drugs / interventions tested

Blood draw — full drug profile →
Neurocognitive testing
Medical questionnaire

Conditions studied

Dementia, Early Onset — all drugs for Dementia, Early Onset →

Sponsor

Columbia University

Who can join

18 and older, any sex, with Dementia, Early Onset. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood draw

Trials testing the same drug.

NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
NCT07252622 — Progesterone Levels and Frozen Embryo Transfer Outcomes · not yet recruiting
NCT07382076 — Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population · active not recruiting
NCT06011824 — A Study of Effect of Megakaryocytes and Platelets in Breast Cancer · completed
NCT05912400 — Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1 · completed

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04906863 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 29 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04906863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing